The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Opportunities and Challenges in Antiparasitic Drug Discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Qinghaosu (Artemisinin): an Antimalarial Drug from China
Klayman, D. L. (1985) · Science · doi:10.1126/science.3887571 · Cited by 2,186
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs
Jomaa, H., Wiesner, J., Sanderbrand, S., Altincicek, B., Weidemeyer, C., Hintz, M., Türbachova, I., Eberl, M., Zeidler, J., Lichtenthaler, H. K., et al. (1999) · Science · doi:10.1126/science.285.5433.1573 · Cited by 1,173
Hit and lead generation: beyond high-throughput screening
Bleicher, K. H., Böhm, H.-J., Müller, K., & Alanine, A. I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1086 · Cited by 1,056
Drug development for neglected diseases: a deficient market and a public-health policy failure
Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R., & Ford, N. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09096-7 · Cited by 893
Antimalarial drug discovery: efficacy models for compound screening
Fidock, D. A., Rosenthal, P. J., Croft, S. L., Brun, R., & Nwaka, S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1416 · Cited by 861
Cysteine proteases of parasitic organisms
Sajid, M., & McKerrow, J. H. (2002) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(01)00438-8 · Cited by 794
Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum
Waller, R. F., Keeling, P. J., Donald, R. G. K., Striepen, B., Handman, E., Lang-Unnasch, N., Cowman, A. F., Besra, G. S., Roos, D. S., & McFadden, G. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12352 · Cited by 714
Räz, B., Iten, M., Grether-Bühler, Y., Kaminsky, R., & Brun, R. (1997) · Acta Tropica · doi:10.1016/s0001-706x(97)00079-x · Cited by 688
CONQUERING THE INTOLERABLE BURDEN OF MALARIA: WHAT’S NEW, WHAT’S NEEDED: A SUMMARY
BREMAN, J. G., ALILIO, M. S., & MILLS, A. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.2_suppl.0700001 · Cited by 677
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Mode of action of benzimidazoles
Lacey, E. (1990) · Parasitology Today · doi:10.1016/0169-4758(90)90227-u · Cited by 594
Specific chemotherapy of Chagas disease: controversies and advances
Urbina, J. A., & Docampo, R. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.001 · Cited by 567
Modes of action of anthelmintic drugs
Martin, R. J. (1997) · The Veterinary Journal · doi:10.1016/s1090-0233(05)80005-x · Cited by 538
Fry, M., & Pudney, M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90213-3 · Cited by 529
Burger's Medicinal Chemistry and Drug Discovery
Abraham, D. J. (2003) · Wiley eBooks · doi:10.1002/0471266949 · Cited by 499
Miltefosine, an Oral Agent, for the Treatment of Indian Visceral Leishmaniasis
Jha, T. K., Sundar, S., Thakur, C. P., Bachmann, P., Karbwang, J., Fischer, C., Voss, A., & Berman, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412403 · Cited by 468
Triglia, T., Menting, J. G. T., Wilson, C., & Cowman, A. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13944 · Cited by 422
Insights into antifolate resistance from malarial DHFR-TS structures
Yuvaniyama, J., Chitnumsub, P., Kamchonwongpaisan, S., Vanichtanankul, J., Sirawaraporn, W., Taylor, P., Walkinshaw, M. D., & Yuthavong, Y. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb921 · Cited by 419
Surolia, N., & Surolia, A. (2001) · Nature Medicine · doi:10.1038/84612 · Cited by 412
Traditional herbal medicines for malaria
Willcox, M. L., & Bodeker, G. (2004) · BMJ · doi:10.1136/bmj.329.7475.1156 · Cited by 374
Cysteine proteases of malaria parasites
Rosenthal, P. J. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2004.10.003 · Cited by 318
Antiparasitic properties of medicinal plants and other naturally occurring products
TAGBOTO, S., & TOWNSON, S. (2001) · Advances in Parasitology · doi:10.1016/s0065-308x(01)50032-9 · Cited by 308
The life and times of ivermectin — a success story
Õmura, S., & Crump, A. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1048 · Cited by 273
Virtual drug discovery and development for neglected diseases through public–private partnerships
Nwaka, S., & Ridley, R. G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1230 · Cited by 260
Eflornithine for the treatment of human African trypanosomiasis
Burri, C., & Brun, R. (2003) · Parasitology Research · doi:10.1007/s00436-002-0766-5 · Cited by 227
Kremsner, P. G., & Krishna, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16680-4 · Cited by 226
Widdus, R. (2017) · Global Health · doi:10.4324/9781315254227-32 · Cited by 225
Yeh, I., Hanekamp, T., Tsoka, S., Karp, P. D., & Altman, R. B. (2004) · Genome Research · doi:10.1101/gr.2050304 · Cited by 224
Antibiotics: Where did we go wrong?
Overbye, K. M., & Barrett, J. F. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03285-4 · Cited by 223
In vivo antimalarial activity of the beta-carboline alkaloid manzamine A
Ang, K. K. H., Holmes, M. J., Higa, T., Hamann, M. T., & Kara, U. A. K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1645-1649.2000 · Cited by 218
Fosmidomycin, a Novel Chemotherapeutic Agent for Malaria
Lell, B., Ruangweerayut, R., Wiesner, J., Missinou, M. A., Schindler, A., Baranek, T., Hintz, M., Hutchinson, D., Jomaa, H., & Kremsner, P. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.735-738.2003 · Cited by 216
Looareesuwan, S., Chulay, J. D., Canfield, C. J., & Hutchinson, D. B. (1999) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1999.60.533 · Cited by 215
Baldwin, J., Michnoff, C. H., Malmquist, N. A., White, J., Roth, M. G., Rathod, P. K., & Phillips, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501100200 · Cited by 197
Peters, W., Robinson, B. L., Mutambu, S. L., Warhurst, D. C., Ellis, D. S., & Tovey, D. G. (1989) · Annals of Tropical Medicine & Parasitology · doi:10.1080/00034983.1989.11812304 · Cited by 193
Biot, C., Taramelli, D., Forfar-Bares, I., Maciejewski, L. A., Boyce, M., Nowogrocki, G., Brocard, J. S., Basilico, N., Olliaro, P., & Egan, T. J. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500061 · Cited by 192
Phillips, M. A., Coffino, P., & Wang, C. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47475-3 · Cited by 179
High-throughput drug discovery: What can we expect from HTS?
Gribbon, P., & Andreas, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03275-1 · Cited by 174
Current situation of African trypanosomiasis
Kuzoe, F. A. S. (1993) · Acta Tropica · doi:10.1016/0001-706x(93)90089-t · Cited by 173
Public – private 'partnerships' in health – a global call to action
Nishtar, S. (2004) · Health Research Policy and Systems · doi:10.1186/1478-4505-2-5 · Cited by 168
Experimental models of Schistosoma mansoni infection
Cheever, A. W., Lenzi, J. A., Lenzi, H. L., & Andrade, Z. A. (2002) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762002000700002 · Cited by 159
O’Neill, P. M., Mukhtar, A., Stocks, P. A., Randle, L. E., Hindley, S., Ward, S. A., Storr, R. C., Bickley, J. F., O’Neil, I. A., Maggs, J. L., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030796n · Cited by 146
Cameron, A., Read, J. A., Tranter, R., Winter, V. J., Sessions, R. B., Brady, R. L., Vivas, L., Easton, A., Kendrick, H. D., Croft, S. L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402433200 · Cited by 144
The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in Humans
Cotreau, M. M., Warren, S., Ryan, J. L., Fleckenstein, L. L., Vanapalli, S. R., Brown, K. R., Rock, D., Chen, C., & Schwertschlag, U. S. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003257456 · Cited by 137
Chemistry-to-gene screens in Caenorhabditis elegans
Jones, A. K., Buckingham, S. D., & Sattelle, D. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1692 · Cited by 130
Blackman, M. J. (2000) · Current Drug Targets · doi:10.2174/1389450003349461 · Cited by 127
Taking inventory: antibacterial agents currently at or beyond Phase 1
Bush, K., Macielag, M. J., & Weidner‐Wells, M. A. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.08.013 · Cited by 126
Specialized Fatty Acid Synthesis in African Trypanosomes: Myristate for GPI Anchors
Morita, Y. S., Paul, K. S., & Englund, P. T. (2000) · Science · doi:10.1126/science.288.5463.140 · Cited by 126
Cioli, D., Botros, S. S., Wheatcroft-Francklow, K., Mbaye, A. I., Southgate, V. R., Tchuenté, L.-A. T., Pica‐Mattoccia, L., Troiani, A. R., el-Din, S. H. S., Sabra, A.-N. A., et al. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2004.05.001 · Cited by 126
Hudson, A. T., Dickins, M., Ginger, C. D., et al. (1991) · PubMed · Cited by 123
Self-citationSaravanamuthu, A., Vickers, T. J., Bond, C. S., Peterson, M. R., Hunter, W. N., & Fairlamb, A. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403187200 · Cited by 108
Fosmidomycin‐Clindamycin forPlasmodium falciparumInfections in African Children
Borrmann, S., Adégnika, A. A., Matsiegui, P., Issifou, S., Schindler, A., Mawili-Mboumba, D. P., Baranek, T., Wiesner, J., Jomaa, H., & Kremsner, P. G. (2004) · The Journal of Infectious Diseases · doi:10.1086/381785 · Cited by 106
In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel
Liang, Y.-S., Coles, G. C., Doenhoff, M. J., et al. (2001) · International Journal for Parasitology · doi:10.1016/s0020-7519(01)00246-6 · Cited by 100
Kemp, L. E., Bond, C. S., & Hunter, W. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102679799 · Cited by 99
Molecular biology and electrophysiology of glutamategated chloride channels of invertebrates
Cully, D. F., Wilkinson, H. A., Vassilatis, D. K., Etter, A., & Arena, J. P. (1996) · Parasitology · doi:10.1017/s0031182000077970 · Cited by 96
Maes, L. J. R. M., Berghe, D. V., Germonprez, N., Quirijnen, L., Cos, P., KIMPE, N. D., & Puyvelde, L. V. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.130-136.2004 · Cited by 94
Utzinger, J., Chollet, J., Tu, Z., et al. (2002) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(02)90110-0 · Cited by 85
Thomson, C. J., Power, E., Rübsamen‐Waigmann, H., & Labischinski, H. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.08.009 · Cited by 84
Antimalarial Activities of Novel SyntheticCysteine ProteaseInhibitors
Lee, B. J., Singh, A., Chiang, P., Kemp, S. J., Goldman, E. A., Weinhouse, M. I., Vlasuk, G. P., & Rosenthal, P. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3810-3814.2003 · Cited by 80
Cyclin-dependent kinase homologues of Plasmodium falciparum
Doerig, C., Endicott, J., & Chakrabarti, D. (2002) · International Journal for Parasitology · doi:10.1016/s0020-7519(02)00186-8 · Cited by 79
Yardley, V., & Croft, S. L. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.61.193 · Cited by 46
An α‐proteobacterial type malate dehydrogenase may complement LDH function in Plasmodium falciparum
Tripathi, A. K., Desai, P. V., Pradhan, A., Khan, S. I., Avery, M. A., Walker, L., & Tekwani, B. L. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04281.x · Cited by 46
Kasekarn, W., Sirawaraporn, R., Chahomchuen, T., Cowman, A. F., & Sirawaraporn, W. (2004) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2004.04.012 · Cited by 30
Research on infectious diseases requires better coordination
Ridley, R. G. (2004) · Nature Medicine · doi:10.1038/nm1153 · Cited by 24
Yeates, C. L. (2003) · PubMed · Cited by 24
Townson, S., Dobinson, A. R., Connelly, C., & Muller, R. (1988) · Journal of Helminthology · doi:10.1017/s0022149x00011494 · Cited by 22
Tuberculosis – strategies towards anti-infectives for a chronic disease
Barry, C. E., & Duncan, K. (2004) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2004.10.007 · Cited by 9
Jp, C., Stables, J. N., Lees, G. M., Martin-Short, M. R., & Rankin, R. B. (1988) · Journal of Helminthology · doi:10.1017/s0022149x00011123 · Cited by 9
Cited by
Anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept’
Cos, P., Vlietinck, A. J., Berghe, D. V., & Maes, L. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.04.003 · Cited by 1,603
Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases
Brenk, R., Schipani, A., James, D., Krasowski, A., Gilbert, I. H., Frearson, J., & Wyatt, P. G. (2008) · ChemMedChem · doi:10.1002/cmdc.200700139 · Cited by 709
Innovative lead discovery strategies for tropical diseases
Nwaka, S., & Hudson, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2144 · Cited by 521
Self-citationDrug repurposing and human parasitic protozoan diseases
Andrews, K. T., Fisher, G., & Skinner-Adams, T. S. (2014) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2014.02.002 · Cited by 383
Enzyme Inhibitor Discovery by Activity-Based Protein Profiling
Niphakis, M. J., & Cravatt, B. F. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035708 · Cited by 366
Metadata
- Authors
- Pink, R., Hudson, A., Mouriès, M.-A., & Bendig, M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-09-01
- Volume
- 4
- Issue
- 9
- Pages
- 727-740
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2015620110
- Cited by
- 545
- References
- 68
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.